pharmaphorum

DECEMBER 16, 2022

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Optibrium, another software developer in the AI drug discovery space, has appointed Ian Smith as its new chief technology officer. McKinnell, Jr. to support the company’s growth.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

pharmaphorum

JANUARY 27, 2022

I observed that my colleagues who were working to develop and validate various clinical applications of virtual reality technology had no venue to publish their work in a way that would reach other scientists grappling with the same issues and constraints,” Greenleaf said.

Production 142

Production Behavioural Health Development Clinical Trials 142

Drug Discovery World

JANUARY 12, 2023

Here, Thomas reflects specifically on Anita Cooper’s prediction relating to the importance of clinical trials. . Following the launch of Protas, DDW spoke with Protas Chief Executive, Professor Sir Martin Landray, who echoed Cooper’s emphasis on the importance of clinical trial design.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97